Canada’s Vaccine Development Capacity and the Federal Government’s Management of COVID-19

Download Full Article Article Brief

Summary

Paul Lucas

Canadian Health Policy, December 2020. ISSN 2562-9492 www.canadianhealthpolicy.com

ABSTRACT

Why is Canada lagging the rest of the world in developing and rolling out a COVID-19 vaccine? Why is Canada down the priority list of countries to receive supplies of vaccine? Why does Canada not have the capability to produce vaccine for COVID-19? Despite numerous outreach efforts by the industry over the years, successive governments, including the current one, have done little to nothing to create a favourable pharmaceutical policy environment. They have made no effort to work with the innovative industry to encourage a partnership which would deliver tremendous value to the healthcare system and the economy and give Canadians early access to new medicines and vaccines.

AUTHOR AFFILIATIONS

Retired President and CEO GlaxoSmithKline.

SUBMISSION DATE

November 30, 2020

PUBLICATION DATE

December 1, 2020

DISCLOSURE

None declared. 

Subscribe image

CHP blogazine

Opinions

News